Päffikon (SZ) Switzerland 19th of April 2021: Saiba Animal Health reported today that the rights for its two lead assets, SAH001 (HypoCat) and SAH003 (CAD vaccine) have been transferred from Benchmark Animal Health to a leading global Animal Health Company. In 2014 and in 2015, Saiba Animal Heath (HypoPet AG) and Benchmark Holdings PLC entered …Read More
Archive: April 19, 2021
- Saiba Animal Health AG announces a new out-licensing agreement
- Saiba Animal Health AG’s executes a development and commercialization license for a second product candidate.
- Saiba Animal Health AG selected to present at the 6th Annual Animal Health, Nutrition and Technology Innovation Forum, USA.
- Saiba Animal Health AG’s executes a license for the development and commercialization of a lead product candidate.
- Saiba Animal Health AG Signs Second Agreement with Boehringer Ingelheim